• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical Practice Guidelines in Cardio-Oncology: A Sea of Opportunity.

作者信息

Sase Kazuhiro, Mukai Mikio, Fujiwara Yasuhiro

机构信息

Clinical Pharmacology and Regulatory Science, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

Institute for Medical Regulatory Science, Organization for University Research Initiatives, Waseda University, Tokyo, Japan.

出版信息

JACC CardioOncol. 2022 Dec 6;5(1):145-148. doi: 10.1016/j.jaccao.2022.11.001. eCollection 2023 Feb.

DOI:10.1016/j.jaccao.2022.11.001
PMID:36875908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9982292/
Abstract
摘要

相似文献

1
Clinical Practice Guidelines in Cardio-Oncology: A Sea of Opportunity.心脏肿瘤学临床实践指南：机遇之海
JACC CardioOncol. 2022 Dec 6;5(1):145-148. doi: 10.1016/j.jaccao.2022.11.001. eCollection 2023 Feb.
2
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).心血管影像学在接受心脏毒性治疗的癌症患者中的作用：代表心力衰竭协会（HFA）、欧洲心血管影像协会（EACVI）和欧洲心脏病学会心脏肿瘤学委员会（ESC）的立场声明。
Eur J Heart Fail. 2020 Sep;22(9):1504-1524. doi: 10.1002/ejhf.1957. Epub 2020 Aug 21.
3
[2022 ESC guidelines on cardio-oncology : Understanding and treating cardiovascular side effects from cancer therapy].[2022年欧洲心脏病学会心脏肿瘤学指南：理解和治疗癌症治疗的心血管副作用]
Herz. 2023 Feb;48(1):15-22. doi: 10.1007/s00059-022-05149-z. Epub 2022 Nov 28.
4
Cardio-oncology: where do we stand for in Belgium?心血管肿瘤学：在比利时，我们处于什么地位？
Acta Cardiol. 2021 Apr;76(2):204-208. doi: 10.1080/00015385.2020.1713521. Epub 2020 Jan 22.
5
First European Society of Cardiology Cardio-Oncology Guidelines: A Big Leap Forward for an Emerging Specialty.首部欧洲心脏病学会心脏肿瘤学指南：新兴专业的巨大飞跃。
Heart Lung Circ. 2022 Dec;31(12):1563-1567. doi: 10.1016/j.hlc.2022.11.003.
6
The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.肿瘤心脏病学计划：心血管疾病癌症患者护理的多学科方法。
Can J Cardiol. 2016 Jul;32(7):847-51. doi: 10.1016/j.cjca.2016.04.014. Epub 2016 May 6.
7
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.血清生物标志物在接受心脏毒性癌症治疗的癌症患者中的作用：心力衰竭协会的心脏肿瘤学研究小组和欧洲心脏病学会的心脏肿瘤学理事会的立场声明。
Eur J Heart Fail. 2020 Nov;22(11):1966-1983. doi: 10.1002/ejhf.2017. Epub 2020 Oct 20.
8
ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.美国心脏病学会适当使用标准专家组、美国胸外科学会、美国心脏协会、美国超声心动图学会、欧洲心血管外科学会、心脏瓣膜学会、心血管麻醉师学会、心血管血管造影和介入学会、心血管计算机断层扫描学会、心血管磁共振学会和胸外科医师学会 2017 年严重主动脉瓣狭窄患者治疗的适当使用标准：报告
J Am Soc Echocardiogr. 2018 Feb;31(2):117-147. doi: 10.1016/j.echo.2017.10.020. Epub 2017 Dec 16.
9
The European Society of Cardiology Cardio-Oncology Guidelines: Evidence Base, Actionability, and Relevance to Clinical Practice.欧洲心脏病学会心脏肿瘤学指南：循证基础、可操作性及与临床实践的相关性
JACC CardioOncol. 2022 Dec 6;5(1):137-140. doi: 10.1016/j.jaccao.2022.10.009. eCollection 2023 Feb.
10
Joining Forces: Establishing a Cardio-oncology Clinic.携手合作：建立心脏肿瘤诊所。
J Adv Pract Oncol. 2018 Mar;9(2):222-229. Epub 2018 Mar 1.

引用本文的文献

1
Breaking the One-Size-Fits-All Approach in Cardio-Oncology: Applying the BEST to Optimize Cardiotoxicity Monitoring.打破心血管肿瘤学中“一刀切”的方法：应用BEST优化心脏毒性监测。
JACC CardioOncol. 2025 Jun;7(4):442-444. doi: 10.1016/j.jaccao.2025.05.007.
2
Association Between Amount of Physical Activity and Clinical Outcomes After Treatment for Cardiovascular Disease in Cancer Survivors.癌症幸存者心血管疾病治疗后体力活动量与临床结局之间的关联
Circ Rep. 2024 Nov 14;6(12):547-554. doi: 10.1253/circrep.CR-24-0105. eCollection 2024 Dec 10.
3
Real-world data of cardio-oncologic interventions for cardiovascular adverse events with oral oncolytics.口服肿瘤治疗药物引起心血管不良事件的心脏肿瘤干预的真实世界数据。
Cardiooncology. 2024 Apr 9;10(1):22. doi: 10.1186/s40959-024-00221-5.

本文引用的文献

1
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).2022年欧洲心脏病学会（ESC）与欧洲血液学协会（EHA）、欧洲治疗放射学与肿瘤学协会（ESTRO）以及国际心脏肿瘤学会（IC-OS）合作制定的心脏肿瘤学指南。
Eur Heart J. 2022 Nov 1;43(41):4229-4361. doi: 10.1093/eurheartj/ehac244.
2
Clinical Practice Guidelines in Cardio-Oncology.心血管肿瘤学临床实践指南。
Heart Fail Clin. 2022 Jul;18(3):489-501. doi: 10.1016/j.hfc.2022.02.002. Epub 2022 Jun 1.
3
Cardio-Oncology in Japan: The Rapidly Rising Sun.日本的心脏肿瘤学：旭日东升。
JACC CardioOncol. 2020 Dec 15;2(5):815-818. doi: 10.1016/j.jaccao.2020.10.014. eCollection 2020 Dec.
4
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines.心血管毒性与癌症治疗相关：对美国和欧洲心血管肿瘤学指南的务实方法。
J Am Heart Assoc. 2020 Sep 15;9(18):e018403. doi: 10.1161/JAHA.120.018403. Epub 2020 Sep 5.
5
Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity.改变观念：改善癌症治疗相关心脏毒性的结局。
Curr Oncol Rep. 2019 Jan 30;21(1):9. doi: 10.1007/s11912-019-0751-0.
6
Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?蒽环类药物治疗的心脏毒性作用：有哪些证据和潜在危害？
Lancet Oncol. 2017 Aug;18(8):e445-e456. doi: 10.1016/S1470-2045(17)30535-1. Epub 2017 Jul 26.
7
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).2016年欧洲心脏病学会（ESC）实践指南委员会主持制定的关于癌症治疗与心血管毒性的立场文件：欧洲心脏病学会（ESC）癌症治疗与心血管毒性特别工作组。
Eur Heart J. 2016 Sep 21;37(36):2768-2801. doi: 10.1093/eurheartj/ehw211. Epub 2016 Aug 26.
8
Research methods to change clinical practice for patients with rare cancers.改变罕见癌症患者临床实践的研究方法。
Lancet Oncol. 2016 Feb;17(2):e70-e80. doi: 10.1016/S1470-2045(15)00396-4.
9
Cardiac Surveillance Guidelines for Trastuzumab-Containing Therapy in Early-Stage Breast Cancer: Getting to the Heart of the Matter.早期乳腺癌含曲妥珠单抗治疗的心脏监测指南：抓住问题的核心
J Clin Oncol. 2016 Apr 1;34(10):1030-3. doi: 10.1200/JCO.2015.64.5515. Epub 2016 Feb 1.